secwatch.observer — SEC 8-K summary
======================================

Issuer:     Savara Inc (SVRA)
CIK:        0001160308
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001193125-25-005034
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Savara updates corporate presentation; no material new information disclosed
----------------------------------------------------------------------------

- Corporate presentation updated and posted on IR website on January 13, 2025.
- Presentation titled 'Developing New Therapies for Rare Respiratory Diseases'.
- No specific financial data or material events provided in the filing.
- Presentation furnished as Exhibit 99.1 but contains no new material substantive disclosures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1160308/000119312525005034/0001193125-25-005034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1160308/000119312525005034/d912056d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-005034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer